Research Topics
| Larry KarnitzSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combinationAmelia M Huehls
Division of Oncology Research, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA
Mol Pharmacol 82:767-76. 2012....
Cdc37 regulation of the kinome: when to hold 'em and when to fold 'emLarry M Karnitz
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Sci STKE 2007:pe22. 2007..However, new evidence suggests that most kinases do require chaperoning and, furthermore, that Cdc37, a chaperone that has Hsp90-dependent and -independent functions, serves as the chaperone for a large portion of the yeast kinome...
Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survivalLarry M Karnitz
Division of Oncology Research, Guggenheim 13, Mayo Clinic College of Medicine, 200 First Street, S W, Rochester, Minnesota 55905, USA
Mol Pharmacol 68:1636-44. 2005....
Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stressSonnet J H Arlander
Department of Molecular Pharmacology, Mayo Graduate School, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Biol Chem 278:52572-7. 2003..Collectively, our studies identify Chk1 as a novel Hsp90 client and suggest that pharmacologic inhibition of Hsp90 may sensitize tumor cells to chemotherapeutic agents by disrupting Chk1 function during replication stress...
Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complexEdgardo R Parrilla-Castellar
Tumor Biology Program, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
DNA Repair (Amst) 3:1009-14. 2004..Taken together, these findings suggest that the 9-1-1 clamp is a multifunctional complex that is loaded onto DNA at sites of damage, where it coordinates checkpoint activation and DNA repair...
Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survivalJill M Wagner
Department of Molecular Pharmacology and Experimental Therapeutics and Division of Oncology Research, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA
Mol Pharmacol 76:208-14. 2009..In fact, Chk1 depletion reversed the sensitivity seen when Rad18 was disabled. Collectively, these studies suggest that the pharmacological manipulation of Chk1 may not be an effective strategy to sensitize tumors to platinating agents...
Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisiae complex involved in sister chromatid cohesion establishmentCarolin J Merkle
Graduate Program in Tumor Biology, Mayo Graduate School, Rochester, Minnesota 55905, USA
J Biol Chem 278:30051-6. 2003..Our data provide evidence for the existence of an alternative RFC complex with a probable role in mammalian sister chromatid cohesion establishment...
Functioning of the Hsp90 machine in chaperoning checkpoint kinase I (Chk1) and the progesterone receptor (PR)Sara J Felts
Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Cell Stress Chaperones 12:353-63. 2007..Importantly, the cochaperones Hop and Cdc37 cooperate as the kinase transitions from immature Hsp70- to mature Hsp90-predominant complexes...
Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathwayCatherine J Huntoon
Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer Res 70:8642-50. 2010..Taken together, these results identify LATS1 and LATS2 as novel HSP90 clients and show that HSP90 inhibitors can disrupt the LATS tumor suppressor pathway in human cancer cells...
The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1Sinny Delacroix
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Genes Dev 21:1472-7. 2007....
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell linesMarina Galvez-Peralta
Division of Oncology Research and Department of Molecular Pharmacology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Mol Pharmacol 74:724-35. 2008..These results collectively suggest that S-phase-selective agents might exhibit more cytotoxicity when administered sequentially rather than simultaneously...
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabineRuben A Mesa
Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Blood 106:318-27. 2005..Collectively, these results suggest that treatment with 17-AAG might represent a means of reversing checkpoint-mediated cytarabine resistance in AML...
The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisonsKaren Flatten
Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Biol Chem 280:14349-55. 2005..Collectively, these results show that the ATR/Chk1 pathway plays a predominant role in the response to topoisomerase I inhibitors in carcinoma cells and identify a potential approach for enhancing the efficacy of these drugs...
Cut5 is required for the binding of Atr and DNA polymerase alpha to genotoxin-damaged chromatinEdgardo R Parrilla-Castellar
Tumor Biology Program, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Biol Chem 278:45507-11. 2003..Taken together, these results demonstrate that Cut5 plays an integral role in the recruitment and assembly of the Chk1 signaling cascade components following DNA damage...
Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling eventPia Roos-Mattjus
Department of Biochemistry and Molecular Biology, Mayo Graduate School, Rochester, Minnesota 55905, USA
J Biol Chem 277:43809-12. 2002..Collectively, these studies demonstrate that 9-1-1 chromatin binding is a proximal event in the checkpoint signaling cascade...
Rad9 protects cells from topoisomerase poison-induced cell deathDavid Loegering
Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA
J Biol Chem 279:18641-7. 2004..Collectively, these results suggest that the predominant role of Rad9 in ES cells is to promote survival after replicative stress and topoisomerase-mediated DNA damage...
Identification and characterization of RAD9B, a paralog of the RAD9 checkpoint geneVanessa M Dufault
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Genomics 82:644-51. 2003..Taken together, these results suggest that these proteins can combinatorially assemble into distinct 9-1-1 clamps that may have distinct biological functions...
Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instabilityJennifer M Leonard
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA
J Cell Biol 183:385-91. 2008..These results suggest that inappropriate Shh pathway activation promotes tumorigenesis by disabling a key signaling pathway that helps maintain genomic stability and inhibits tumorigenesis...
Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signalingPia Roos-Mattjus
Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Biol Chem 278:24428-37. 2003..Collectively, these results demonstrate that the Rad9 phospho-tail is a key participant in the Chk1 activation pathway and point to additional roles for Rad9 in cellular responses to IR...
S-peptide epitope tagging for protein purification, expression monitoring, and localization in mammalian cellsJennifer S Hackbarth
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Biotechniques 37:835-9. 2004..These reagents make the S-peptide/S-protein system an attractive alternative to currently available epitope tagging methods...
Purification and identification of protein complexes that control the cell cycleMatthew A Burtelow
Division of Oncology Research, Mayo Clinic, Rochester, MN, USA
Methods Mol Biol 241:247-53. 2004
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivoDavid J Matthews
Exelixis Inc, South San Francisco, California 94083, USA
Cell Cycle 6:104-10. 2007..Together, these data show that cell cycle checkpoint inhibitors may have significant clinical utility in potentiating the activity of gemcitabine...
Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperonesSonnet J H Arlander
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Graduate School
J Biol Chem 281:2989-98. 2006....
Research Grants
- Analysis of a DNA Damage-Inducible Checkpoint ComplexLarry Karnitz; Fiscal Year: 2007..Collectively, these studies will provide new insights into how the 911 complexes direct downstream events that regulate checkpoint activation, cell survival, and genomic stability. ..
- Therapeutic targeting of HSP90-dependent signalingLarry Karnitz; Fiscal Year: 2007..Collectively, these studies will provide information about the ability to alter the response of ovarian cancer cells to chemotherapeutic agents in vitro and in the clinical setting. ..
- ANALYSIS OF A DNA DAMAGE INDUCIBLE CHECKPOINT COMPLEXLarry Karnitz; Fiscal Year: 2003..Additionally, understanding the molecular details of this pathway will identify novel targets to sensitize cells to therapeutic DNA-damaging agents, such as ionizing radiation and anti-tumor chemotherapeutics. ..
